SrasV1, PascalFrancis, Corpus, bibRecord, 000325

'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam

Identifieur interne : 000325 ( PascalFrancis/Corpus ); précédent : 000324; suivant : 000326

'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam

Auteurs : Theodore M. Hammett ; ZUNYOU WU ; TRAN TIEN DUC ; David Stephens ; Sheena Sullivan ; WEI LIU ; YI CHEN ; Doan Ngu ; Don C. Des Jarlais

Source :

Addiction : (Abingdon. Print) [ 0965-2140 ] ; 2008.

RBID : Francis:08-0099532

Descripteurs français

Pascal (Inist)
- Toxicomanie, Aspect social, Santé publique, Addiction, Danger, Réduction, Politique sanitaire, Environnement, Virus immunodéficience humaine, SIDA, Prévention, Voie intraveineuse, Drogue illicite, Chine, Vietnam, Homme, Psychiatrie, Psychologie.

English descriptors

KwdEn :
- AIDS, Addiction, China, Danger, Drug addiction, Environment, Health policy, Human, Human immunodeficiency virus, Illicit drug, Intravenous administration, Prevention, Psychiatry, Psychology, Public health, Reduction, Social aspect, Vietnam.

Abstract

Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0965-2140`
A03		`1`		`@0 Addiction : (Abingd. Print)`
A05				`@2 103`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam`
A11	`01`	`1`		`@1 HAMMETT (Theodore M.)`
A11	`02`	`1`		`@1 ZUNYOU WU`
A11	`03`	`1`		`@1 TRAN TIEN DUC`
A11	`04`	`1`		`@1 STEPHENS (David)`
A11	`05`	`1`		`@1 SULLIVAN (Sheena)`
A11	`06`	`1`		`@1 WEI LIU`
A11	`07`	`1`		`@1 YI CHEN`
A11	`08`	`1`		`@1 NGU (Doan)`
A11	`09`	`1`		`@1 DES JARLAIS (Don C.)`
A14	`01`			`@1 Abt Associates Inc @2 Cambridge, MA @3 USA @Z 1 aut.`
A14	`02`			`@1 National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention @2 Beijing @3 CHN @Z 2 aut. @Z 5 aut.`
A14	`03`			`@1 Health Policy Initiative @2 Hanoi @3 VNM @Z 3 aut. @Z 4 aut.`
A14	`04`			`@1 Guangxi Center for HIV/AIDS Prevention and Control @2 Manning @3 CHN @Z 6 aut. @Z 7 aut.`
A14	`05`			`@1 Consultant to Lang Son Provincial Health Service, Ho Chi Minh City @3 VNM @Z 8 aut.`
A14	`06`			`@1 Beth Israel Medical Center New York @2 NY @3 USA @Z 9 aut.`
A20				`@1 137-145`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 12616 @5 354000183410820140`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 45 ref.`
A47	`01`	`1`		`@0 08-0099532`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Addiction : (Abingdon. Print)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.
C02	`01`	`X`		`@0 770D03E01 @1 IV`
C03	`01`	`X`	`FRE`	`@0 Toxicomanie @5 01`
C03	`01`	`X`	`ENG`	`@0 Drug addiction @5 01`
C03	`01`	`X`	`SPA`	`@0 Toxicomanía @5 01`
C03	`02`	`X`	`FRE`	`@0 Aspect social @5 02`
C03	`02`	`X`	`ENG`	`@0 Social aspect @5 02`
C03	`02`	`X`	`SPA`	`@0 Aspecto social @5 02`
C03	`03`	`X`	`FRE`	`@0 Santé publique @5 03`
C03	`03`	`X`	`ENG`	`@0 Public health @5 03`
C03	`03`	`X`	`SPA`	`@0 Salud pública @5 03`
C03	`04`	`X`	`FRE`	`@0 Addiction @2 NM @5 04`
C03	`04`	`X`	`ENG`	`@0 Addiction @2 NM @5 04`
C03	`04`	`X`	`SPA`	`@0 Adicción @2 NM @5 04`
C03	`05`	`X`	`FRE`	`@0 Danger @5 05`
C03	`05`	`X`	`ENG`	`@0 Danger @5 05`
C03	`05`	`X`	`SPA`	`@0 Peligro @5 05`
C03	`06`	`X`	`FRE`	`@0 Réduction @5 06`
C03	`06`	`X`	`ENG`	`@0 Reduction @5 06`
C03	`06`	`X`	`SPA`	`@0 Reducción @5 06`
C03	`07`	`X`	`FRE`	`@0 Politique sanitaire @5 08`
C03	`07`	`X`	`ENG`	`@0 Health policy @5 08`
C03	`07`	`X`	`SPA`	`@0 Política sanitaria @5 08`
C03	`08`	`X`	`FRE`	`@0 Environnement @5 09`
C03	`08`	`X`	`ENG`	`@0 Environment @5 09`
C03	`08`	`X`	`SPA`	`@0 Medio ambiente @5 09`
C03	`09`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 11`
C03	`09`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 11`
C03	`09`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 11`
C03	`10`	`X`	`FRE`	`@0 SIDA @5 12`
C03	`10`	`X`	`ENG`	`@0 AIDS @5 12`
C03	`10`	`X`	`SPA`	`@0 SIDA @5 12`
C03	`11`	`X`	`FRE`	`@0 Prévention @5 17`
C03	`11`	`X`	`ENG`	`@0 Prevention @5 17`
C03	`11`	`X`	`SPA`	`@0 Prevención @5 17`
C03	`12`	`X`	`FRE`	`@0 Voie intraveineuse @5 18`
C03	`12`	`X`	`ENG`	`@0 Intravenous administration @5 18`
C03	`12`	`X`	`SPA`	`@0 Vía intravenosa @5 18`
C03	`13`	`X`	`FRE`	`@0 Drogue illicite @5 19`
C03	`13`	`X`	`ENG`	`@0 Illicit drug @5 19`
C03	`13`	`X`	`SPA`	`@0 Droga ilícita @5 19`
C03	`14`	`X`	`FRE`	`@0 Chine @2 NG @5 20`
C03	`14`	`X`	`ENG`	`@0 China @2 NG @5 20`
C03	`14`	`X`	`SPA`	`@0 China @2 NG @5 20`
C03	`15`	`X`	`FRE`	`@0 Vietnam @2 NG @5 21`
C03	`15`	`X`	`ENG`	`@0 Vietnam @2 NG @5 21`
C03	`15`	`X`	`SPA`	`@0 Vietnam @2 NG @5 21`
C03	`16`	`X`	`FRE`	`@0 Homme @5 22`
C03	`16`	`X`	`ENG`	`@0 Human @5 22`
C03	`16`	`X`	`SPA`	`@0 Hombre @5 22`
C03	`17`	`X`	`FRE`	`@0 Psychiatrie @5 23`
C03	`17`	`X`	`ENG`	`@0 Psychiatry @5 23`
C03	`17`	`X`	`SPA`	`@0 Psiquiatría @5 23`
C03	`18`	`X`	`FRE`	`@0 Psychologie @5 24`
C03	`18`	`X`	`ENG`	`@0 Psychology @5 24`
C03	`18`	`X`	`SPA`	`@0 Psicología @5 24`
C07	`01`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`01`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`02`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`02`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`03`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`03`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`03`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`04`	`X`	`FRE`	`@0 Virose`
C07	`04`	`X`	`ENG`	`@0 Viral disease`
C07	`04`	`X`	`SPA`	`@0 Virosis`
C07	`05`	`X`	`FRE`	`@0 Infection`
C07	`05`	`X`	`ENG`	`@0 Infection`
C07	`05`	`X`	`SPA`	`@0 Infección`
C07	`06`	`X`	`FRE`	`@0 Asie @2 NG`
C07	`06`	`X`	`ENG`	`@0 Asia @2 NG`
C07	`06`	`X`	`SPA`	`@0 Asia @2 NG`
C07	`07`	`X`	`FRE`	`@0 Immunodéficit @5 37`
C07	`07`	`X`	`ENG`	`@0 Immune deficiency @5 37`
C07	`07`	`X`	`SPA`	`@0 Inmunodeficiencia @5 37`
C07	`08`	`X`	`FRE`	`@0 Immunopathologie @5 39`
C07	`08`	`X`	`ENG`	`@0 Immunopathology @5 39`
C07	`08`	`X`	`SPA`	`@0 Inmunopatología @5 39`
N21				`@1 052`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	FRANCIS 08-0099532 INIST
ET :	'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam
AU :	HAMMETT (Theodore M.); ZUNYOU WU; TRAN TIEN DUC; STEPHENS (David); SULLIVAN (Sheena); WEI LIU; YI CHEN; NGU (Doan); DES JARLAIS (Don C.)
AF :	Abt Associates Inc/Cambridge, MA/Etats-Unis (1 aut.); National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention/Beijing/Chine (2 aut., 5 aut.); Health Policy Initiative/Hanoi/Viet Nam (3 aut., 4 aut.); Guangxi Center for HIV/AIDS Prevention and Control/Manning/Chine (6 aut., 7 aut.); Consultant to Lang Son Provincial Health Service, Ho Chi Minh City/Viet Nam (8 aut.); Beth Israel Medical Center New York/NY/Etats-Unis (9 aut.)
DT :	Publication en série; Niveau analytique
SO :	Addiction : (Abingdon. Print); ISSN 0965-2140; Royaume-Uni; Da. 2008; Vol. 103; No. 1; Pp. 137-145; Bibl. 45 ref.
LA :	Anglais
EA :	Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.
CC :	770D03E01
FD :	Toxicomanie; Aspect social; Santé publique; Addiction; Danger; Réduction; Politique sanitaire; Environnement; Virus immunodéficience humaine; SIDA; Prévention; Voie intraveineuse; Drogue illicite; Chine; Vietnam; Homme; Psychiatrie; Psychologie
FG :	Lentivirus; Retroviridae; Virus; Virose; Infection; Asie; Immunodéficit; Immunopathologie
ED :	Drug addiction; Social aspect; Public health; Addiction; Danger; Reduction; Health policy; Environment; Human immunodeficiency virus; AIDS; Prevention; Intravenous administration; Illicit drug; China; Vietnam; Human; Psychiatry; Psychology
EG :	Lentivirus; Retroviridae; Virus; Viral disease; Infection; Asia; Immune deficiency; Immunopathology
SD :	Toxicomanía; Aspecto social; Salud pública; Adicción; Peligro; Reducción; Política sanitaria; Medio ambiente; Human immunodeficiency virus; SIDA; Prevención; Vía intravenosa; Droga ilícita; China; Vietnam; Hombre; Psiquiatría; Psicología
LO :	INIST-12616.354000183410820140
ID :	08-0099532

Links to Exploration step

Francis:08-0099532

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam</title>
<author><name sortKey="Hammett, Theodore M" sort="Hammett, Theodore M" uniqKey="Hammett T" first="Theodore M." last="Hammett">Theodore M. Hammett</name>
<affiliation><inist:fA14 i1="01"><s1>Abt Associates Inc</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zunyou Wu" sort="Zunyou Wu" uniqKey="Zunyou Wu" last="Zunyou Wu">ZUNYOU WU</name>
<affiliation><inist:fA14 i1="02"><s1>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tran Tien Duc" sort="Tran Tien Duc" uniqKey="Tran Tien Duc" last="Tran Tien Duc">TRAN TIEN DUC</name>
<affiliation><inist:fA14 i1="03"><s1>Health Policy Initiative</s1>
<s2>Hanoi</s2>
<s3>VNM</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stephens, David" sort="Stephens, David" uniqKey="Stephens D" first="David" last="Stephens">David Stephens</name>
<affiliation><inist:fA14 i1="03"><s1>Health Policy Initiative</s1>
<s2>Hanoi</s2>
<s3>VNM</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sullivan, Sheena" sort="Sullivan, Sheena" uniqKey="Sullivan S" first="Sheena" last="Sullivan">Sheena Sullivan</name>
<affiliation><inist:fA14 i1="02"><s1>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wei Liu" sort="Wei Liu" uniqKey="Wei Liu" last="Wei Liu">WEI LIU</name>
<affiliation><inist:fA14 i1="04"><s1>Guangxi Center for HIV/AIDS Prevention and Control</s1>
<s2>Manning</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yi Chen" sort="Yi Chen" uniqKey="Yi Chen" last="Yi Chen">YI CHEN</name>
<affiliation><inist:fA14 i1="04"><s1>Guangxi Center for HIV/AIDS Prevention and Control</s1>
<s2>Manning</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ngu, Doan" sort="Ngu, Doan" uniqKey="Ngu D" first="Doan" last="Ngu">Doan Ngu</name>
<affiliation><inist:fA14 i1="05"><s1>Consultant to Lang Son Provincial Health Service, Ho Chi Minh City</s1>
<s3>VNM</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Des Jarlais, Don C" sort="Des Jarlais, Don C" uniqKey="Des Jarlais D" first="Don C." last="Des Jarlais">Don C. Des Jarlais</name>
<affiliation><inist:fA14 i1="06"><s1>Beth Israel Medical Center New York</s1>
<s2>NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0099532</idno>
<date when="2008">2008</date>
<idno type="stanalyst">FRANCIS 08-0099532 INIST</idno>
<idno type="RBID">Francis:08-0099532</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000325</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam</title>
<author><name sortKey="Hammett, Theodore M" sort="Hammett, Theodore M" uniqKey="Hammett T" first="Theodore M." last="Hammett">Theodore M. Hammett</name>
<affiliation><inist:fA14 i1="01"><s1>Abt Associates Inc</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zunyou Wu" sort="Zunyou Wu" uniqKey="Zunyou Wu" last="Zunyou Wu">ZUNYOU WU</name>
<affiliation><inist:fA14 i1="02"><s1>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tran Tien Duc" sort="Tran Tien Duc" uniqKey="Tran Tien Duc" last="Tran Tien Duc">TRAN TIEN DUC</name>
<affiliation><inist:fA14 i1="03"><s1>Health Policy Initiative</s1>
<s2>Hanoi</s2>
<s3>VNM</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stephens, David" sort="Stephens, David" uniqKey="Stephens D" first="David" last="Stephens">David Stephens</name>
<affiliation><inist:fA14 i1="03"><s1>Health Policy Initiative</s1>
<s2>Hanoi</s2>
<s3>VNM</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sullivan, Sheena" sort="Sullivan, Sheena" uniqKey="Sullivan S" first="Sheena" last="Sullivan">Sheena Sullivan</name>
<affiliation><inist:fA14 i1="02"><s1>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wei Liu" sort="Wei Liu" uniqKey="Wei Liu" last="Wei Liu">WEI LIU</name>
<affiliation><inist:fA14 i1="04"><s1>Guangxi Center for HIV/AIDS Prevention and Control</s1>
<s2>Manning</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yi Chen" sort="Yi Chen" uniqKey="Yi Chen" last="Yi Chen">YI CHEN</name>
<affiliation><inist:fA14 i1="04"><s1>Guangxi Center for HIV/AIDS Prevention and Control</s1>
<s2>Manning</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ngu, Doan" sort="Ngu, Doan" uniqKey="Ngu D" first="Doan" last="Ngu">Doan Ngu</name>
<affiliation><inist:fA14 i1="05"><s1>Consultant to Lang Son Provincial Health Service, Ho Chi Minh City</s1>
<s3>VNM</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Des Jarlais, Don C" sort="Des Jarlais, Don C" uniqKey="Des Jarlais D" first="Don C." last="Des Jarlais">Don C. Des Jarlais</name>
<affiliation><inist:fA14 i1="06"><s1>Beth Israel Medical Center New York</s1>
<s2>NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Addiction : (Abingdon. Print)</title>
<title level="j" type="abbreviated">Addiction : (Abingd. Print)</title>
<idno type="ISSN">0965-2140</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Addiction : (Abingdon. Print)</title>
<title level="j" type="abbreviated">Addiction : (Abingd. Print)</title>
<idno type="ISSN">0965-2140</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Addiction</term>
<term>China</term>
<term>Danger</term>
<term>Drug addiction</term>
<term>Environment</term>
<term>Health policy</term>
<term>Human</term>
<term>Human immunodeficiency virus</term>
<term>Illicit drug</term>
<term>Intravenous administration</term>
<term>Prevention</term>
<term>Psychiatry</term>
<term>Psychology</term>
<term>Public health</term>
<term>Reduction</term>
<term>Social aspect</term>
<term>Vietnam</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Toxicomanie</term>
<term>Aspect social</term>
<term>Santé publique</term>
<term>Addiction</term>
<term>Danger</term>
<term>Réduction</term>
<term>Politique sanitaire</term>
<term>Environnement</term>
<term>Virus immunodéficience humaine</term>
<term>SIDA</term>
<term>Prévention</term>
<term>Voie intraveineuse</term>
<term>Drogue illicite</term>
<term>Chine</term>
<term>Vietnam</term>
<term>Homme</term>
<term>Psychiatrie</term>
<term>Psychologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0965-2140</s0>
</fA01>
<fA03 i2="1"><s0>Addiction : (Abingd. Print)</s0>
</fA03>
<fA05><s2>103</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>HAMMETT (Theodore M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ZUNYOU WU</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>TRAN TIEN DUC</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>STEPHENS (David)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SULLIVAN (Sheena)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>WEI LIU</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>YI CHEN</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>NGU (Doan)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DES JARLAIS (Don C.)</s1>
</fA11>
<fA14 i1="01"><s1>Abt Associates Inc</s1>
<s2>Cambridge, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Health Policy Initiative</s1>
<s2>Hanoi</s2>
<s3>VNM</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Guangxi Center for HIV/AIDS Prevention and Control</s1>
<s2>Manning</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Consultant to Lang Son Provincial Health Service, Ho Chi Minh City</s1>
<s3>VNM</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Beth Israel Medical Center New York</s1>
<s2>NY</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA20><s1>137-145</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>12616</s2>
<s5>354000183410820140</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>45 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0099532</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Addiction : (Abingdon. Print)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>770D03E01</s0>
<s1>IV</s1>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Toxicomanie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Drug addiction</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Toxicomanía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Aspect social</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Social aspect</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Aspecto social</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Public health</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Addiction</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Addiction</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Adicción</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Danger</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Danger</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Peligro</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Réduction</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Reduction</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Reducción</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Politique sanitaire</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Health policy</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Política sanitaria</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Environnement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Environment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Medio ambiente</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>SIDA</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>AIDS</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>SIDA</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Prévention</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Prevention</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Prevención</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Voie intraveineuse</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Intravenous administration</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Vía intravenosa</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Drogue illicite</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Illicit drug</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Droga ilícita</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Chine</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>China</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>China</s0>
<s2>NG</s2>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Vietnam</s0>
<s2>NG</s2>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Vietnam</s0>
<s2>NG</s2>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Vietnam</s0>
<s2>NG</s2>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Homme</s0>
<s5>22</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Human</s0>
<s5>22</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Hombre</s0>
<s5>22</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Psychiatrie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Psychiatry</s0>
<s5>23</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Psiquiatría</s0>
<s5>23</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Psychologie</s0>
<s5>24</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Psychology</s0>
<s5>24</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Psicología</s0>
<s5>24</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Asie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fN21><s1>052</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>FRANCIS 08-0099532 INIST</NO>
<ET>'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam</ET>
<AU>HAMMETT (Theodore M.); ZUNYOU WU; TRAN TIEN DUC; STEPHENS (David); SULLIVAN (Sheena); WEI LIU; YI CHEN; NGU (Doan); DES JARLAIS (Don C.)</AU>
<AF>Abt Associates Inc/Cambridge, MA/Etats-Unis (1 aut.); National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention/Beijing/Chine (2 aut., 5 aut.); Health Policy Initiative/Hanoi/Viet Nam (3 aut., 4 aut.); Guangxi Center for HIV/AIDS Prevention and Control/Manning/Chine (6 aut., 7 aut.); Consultant to Lang Son Provincial Health Service, Ho Chi Minh City/Viet Nam (8 aut.); Beth Israel Medical Center New York/NY/Etats-Unis (9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Addiction : (Abingdon. Print); ISSN 0965-2140; Royaume-Uni; Da. 2008; Vol. 103; No. 1; Pp. 137-145; Bibl. 45 ref.</SO>
<LA>Anglais</LA>
<EA>Aims This paper reviews the evolution of government policies in China and Vietnam regarding harm reduction interventions for human immunodeficiency virus (HIV) prevention, such as needle/syringe provision and opioid substitution treatment. Methods The work is based upon the authors' experiences in and observations of these policy developments, as well as relevant government policy documents and legislation. Results Both countries are experiencing HIV epidemics driven by injection drug use and have maintained generally severe policies towards injection drug users (IDUs). In recent years, however, they have also officially endorsed harm reduction. We sought to understand how and why this apparently surprising policy evolution took place. Factors associated with growing support for harm reduction were similar but not identical in China and Vietnam. These included the emergence of effective 'champions' for such policies, an ethos of pragmatism and receptivity to evidence, growing collaboration across public health, police and other sectors, the influence of contingent events such as the severe acute respiratory syndrome (SARS) epidemic and pressure from donors and international organizations to adopt best practice in HIV prevention. Conclusions Ongoing challenges and lessons learned include the persistence of tensions between drug control and harm reduction that may have negative effects on programs until a fully harmonized policy environment is established. Excessive reliance on law enforcement and forced detoxification will not solve the problems of substance abuse or of HIV among drug users. Ongoing evaluation of harm reduction programs, as well as increased levels of multi-sectoral training, collaboration and support are also needed.</EA>
<CC>770D03E01</CC>
<FD>Toxicomanie; Aspect social; Santé publique; Addiction; Danger; Réduction; Politique sanitaire; Environnement; Virus immunodéficience humaine; SIDA; Prévention; Voie intraveineuse; Drogue illicite; Chine; Vietnam; Homme; Psychiatrie; Psychologie</FD>
<FG>Lentivirus; Retroviridae; Virus; Virose; Infection; Asie; Immunodéficit; Immunopathologie</FG>
<ED>Drug addiction; Social aspect; Public health; Addiction; Danger; Reduction; Health policy; Environment; Human immunodeficiency virus; AIDS; Prevention; Intravenous administration; Illicit drug; China; Vietnam; Human; Psychiatry; Psychology</ED>
<EG>Lentivirus; Retroviridae; Virus; Viral disease; Infection; Asia; Immune deficiency; Immunopathology</EG>
<SD>Toxicomanía; Aspecto social; Salud pública; Adicción; Peligro; Reducción; Política sanitaria; Medio ambiente; Human immunodeficiency virus; SIDA; Prevención; Vía intravenosa; Droga ilícita; China; Vietnam; Hombre; Psiquiatría; Psicología</SD>
<LO>INIST-12616.354000183410820140</LO>
<ID>08-0099532</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000325 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000325 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Francis:08-0099532
   |texte=   'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam

'Social evils' and harm reduction : the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri